Di Giuli Riccardo, Cavallero Mattia F, Ferrari Camilla, Vaccari Stefano, Bucci Flavio, Bandi Valeria, Klinger Francesco M, Vinci Valeriano
Plastic Surgery Unit, Department of Medical Biotechnology and Translational Medicine BIOMETRA, Reconstructive and Aesthetic Plastic Surgery School, Humanitas Clinical and Research Hospital, University of Milan, Via Manzoni 56, Rozzano, 20090 Milan, Italy; School of Specialization in Plastic, Reconstructive and Aesthetic Surgery, University of Milan, Milan, Italy.
Plastic Surgery Unit, Department of Medical Biotechnology and Translational Medicine BIOMETRA, Reconstructive and Aesthetic Plastic Surgery School, Humanitas Clinical and Research Hospital, University of Milan, Via Manzoni 56, Rozzano, 20090 Milan, Italy; School of Specialization in Plastic, Reconstructive and Aesthetic Surgery, University of Milan, Milan, Italy.
J Plast Reconstr Aesthet Surg. 2025 May;104:388-397. doi: 10.1016/j.bjps.2025.02.041. Epub 2025 Feb 25.
Implant-based breast reconstruction is the most used approach for breast reconstruction following mastectomy. Prosthetic breast reconstruction helps achieve optimal results with reduced operation time, offering advantages over direct-to-implant and subpectoral reconstruction in selected patients. This study aimed to provide a comprehensive overview of the two-stage prepectoral breast reconstruction.
A systematic literature search was performed, and the search was conducted across the PubMed, Cochrane, and Embase databases by adhering to the preferred reporting items for systematic reviews and meta-analysis guidelines. The inclusion criteria encompassed clinical trials or randomized clinical trials related to completed two-stage prepectoral breast reconstruction. Statistical analyses were conducted to synthesize the data and evaluate outcomes.
A total of 48 articles were included for analysis, evaluating 4461 patients and 3894 breasts. The most commonly performed mastectomy type was skin-sparing mastectomy, followed by nipple-areola complex-sparing mastectomy. For the first surgical step, the mean tissue expander size was 423.64 cc, with a mean final expander fill of 349.10 cc. The mean time between the first and second surgery stages was 6.21 months, and the mean follow-up time was 17.10 months. A total of 21.27% of the patients experienced at least one complication. Specifically, seroma was identified in 11.19%, infection in 8.97%, skin flap necrosis in 8.48%, capsular contracture in 6.74%, rippling/wrinkling in 11.30%, expander or implant exposure in 2.38%, and implant removal in 8.62% of the patients.
Two-stage prepectoral breast reconstruction is a viable surgical option for selected patients. The most frequent complication was seroma. Adjuvant radiotherapy was associated with a higher rate of infection and implant removal.
植入物乳房重建是乳房切除术后最常用的乳房重建方法。假体乳房重建有助于在减少手术时间的情况下获得最佳效果,在特定患者中比直接植入和胸肌下重建具有优势。本研究旨在全面概述两阶段胸肌前乳房重建。
进行了系统的文献检索,按照系统评价和荟萃分析指南的首选报告项目,在PubMed、Cochrane和Embase数据库中进行检索。纳入标准包括与已完成的两阶段胸肌前乳房重建相关的临床试验或随机临床试验。进行统计分析以综合数据并评估结果。
共纳入48篇文章进行分析,评估了4461例患者和3894个乳房。最常进行的乳房切除类型是保留皮肤的乳房切除术,其次是保留乳头乳晕复合体的乳房切除术。对于第一个手术步骤,组织扩张器的平均大小为423.64立方厘米,扩张器的平均最终填充量为349.10立方厘米。第一和第二手术阶段之间的平均时间为6.21个月,平均随访时间为17.10个月。共有21.27%的患者经历了至少一种并发症。具体而言,11.19%的患者出现血清肿,8.97%的患者出现感染,8.48%的患者出现皮瓣坏死,6.74%的患者出现包膜挛缩,11.30%的患者出现波纹/皱纹,2.38%的患者出现扩张器或植入物外露,8.62%的患者进行了植入物取出。
两阶段胸肌前乳房重建对于特定患者是一种可行的手术选择。最常见的并发症是血清肿。辅助放疗与更高的感染率和植入物取出率相关。